文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

体外钾结合治疗在挤压伤无肾模型中的应用

Extracorporeal potassium binding for the management of hyperkalemia in an anephric model of crush injury.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在猪挤压伤无肾模型中,体外钾结合滤芯可控制血钾且不影响血流动力学,可能适用于严酷环境下的高钾血症辅助管理。

该研究为转化科学实验,采用10头约克夏杂交猪建立脾切除+双侧肾切除+失血性休克+膈上主动脉阻断+肢体挤压伤模型,再灌注20分钟后随机分为体外循环加钾结合滤芯组(治疗组)与不加滤芯组(对照组),两组均经血液透析器循环。结果显示治疗组血钾变化ΔK显著低于对照组(1.15 vs 3.75 mmol/L,p=0.03),组间血钾浓度差异显著(p<0.001),平均动脉压、等渗晶体液需求及去甲肾上腺素剂量无差异(p分别为0.14、0.51、0.83),对照组乳酸显著更高(p<0.001)。滤芯在4小时内保持钾结合能力,结束时血钾降低25%(24.9%-27.8%)。作者认为该滤芯可能作为严酷环境下高钾血症管理的辅助手段。

要点

  • 在猪挤压伤无肾模型中,使用钾结合滤芯的体外循环组ΔK为1.15 mmol/L,显著低于对照组的3.75 mmol/L(p=0.03)。
  • 两组间平均动脉压(p=0.14)、等渗晶体液需求(p=0.51)和去甲肾上腺素剂量(p=0.83)无显著差异。
  • 对照组乳酸浓度显著高于治疗组(p<0.001)。
  • 滤芯在不使用透析液的情况下控制血钾,4小时内保持钾结合能力,实验结束时血钾降低25%(24.9%-27.8%)。
  • 作者认为该滤芯可能作为严酷环境下高钾血症管理的辅助手段。

适用人群与场景

  • 约克夏杂交猪,建立脾切除+双侧肾切除+失血性休克+膈上主动脉阻断60分钟+肢体挤压伤模型,再灌注20分钟后随机分组。

处置流程与药物剂量

  • 治疗组:体外循环血液经血液透析器后,超滤液通过含钾结合聚合物的滤芯再回输体外循环;对照组:同样体外循环但不加钾结合滤芯。
  • 两组均用0.9%氯化钠冲击和去甲肾上腺素输注进行复苏。

研究设计与关键结果

  • 转化科学动物实验,10头猪随机分为治疗组(体外循环+钾结合滤芯)和对照组(体外循环不加滤芯)。
  • 主要终点ΔK(血清[K]T390 - 血清[K]T0):对照组3.75(3.27-4.42)mmol/L vs 治疗组1.15(0.62-1.59)mmol/L,治疗组显著更低(p=0.03);组间血钾浓度差异显著(p<0.001)。
  • 平均动脉压(p=0.14)、等渗晶体液需求(p=0.51)、去甲肾上腺素剂量(p=0.83)组间无差异。
  • 对照组乳酸浓度显著更高(p<0.001)。
  • 实验结束时滤芯使血钾降低25%(24.9%-27.8%)。

证据类型、等级与局限

  • 证据类型:转化科学动物实验,证据等级level I。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为钾结合滤芯可能作为严酷环境下高钾血症管理的辅助手段。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Potassium-binding polymers have shown promising results in an anephric porcine hyperkalemia model. The benefits of the polymer in a clinically relevant injury model remain unknown. We hypothesized that potassium-binding cartridges would control serum potassium concentration in a porcine hemorrhagic shock model with supraceliac aortic occlusion and a limb crush injury.

METHODS: Ten Yorkshire-cross swine were anesthetized and instrumented. Pigs underwent splenectomy and bilateral nephrectomy. Hemorrhagic shock was induced for 30 minutes while a leg compression device was applied. Pigs underwent supraceliac aortic occlusion for 60 minutes and were resuscitated with shed blood. The leg compression device was removed 20 minutes after balloon deflation. After 20 minutes of reperfusion, animals were randomized to extracorporeal circulation with (treatment) or without (control) the potassium binding cartridges. In both groups, blood was circulated through a hemodialyzer with a peristaltic pump. In the treatment group, the ultrafiltrate was diverted from the hemodialyzer through cartridges containing the polymer and returned to the extracorporeal circuit. Animals were resuscitated with 0.9% saline boluses and a norepinephrine infusion. The change in serum potassium concentration (ΔK) was calculated as serum [K]T390 - serum [K]T0.

RESULTS: There was a significant difference in serum potassium concentration between groups (p < 0.001). ΔK was significantly higher in the control than the treatment group (3.75 [3.27-4.42] and 1.15 [0.62-1.59] mmol/L, respectively; p = 0.03). There were no differences in mean arterial pressure (p = 0.14), isotonic crystalloids requirement (p = 0.51), or norepinephrine dose (p = 0.83) between groups. Serum lactate concentration was significantly higher in the control group (p < 0.001). At the end of the experiment, the [K] was reduced by 25% (24.9%-27.8%) across the cartridges.

CONCLUSION: The cartridges controlled serum potassium concentrations without dialysate and retained potassium binding capabilities over 4 hours. There were no deleterious effects on hemodynamic parameters. Those cartridges might be beneficial adjuncts for hyperkalemia management in austere environments.

LEVEL OF EVIDENCE: Translational science study, level I.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Hoareau GL, Beyer CA, Wilson C, et al. Extracorporeal potassium binding for the management of hyperkalemia in an anephric model of crush injury. J Trauma Acute Care Surg. 2019. PMID: 30633103. doi:10.1097/TA.0000000000002178

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。